weight loss surgery vs glp-1 Matched subanalysis found no benefit in percent total body for preoperative #GLP-1 RA use controls at 12 months after bariatric surgery, suggesting the effect of these agents may be Bariatric Surgery Yields 5x More

Diabetes Care 41(Suppl 1):S55S64

Critical Considerations: This schedule is purely theoretical and not based on clinical evidence Individual tolerance varies dramaticallysome may not tolerate even these conservative doses Maximum combined doses would likely need to remain below monotherapy maximums (perhaps 2.4 mg cagrilintide + 8 mg retatrutide as absolute ceiling) Medical supervision would be essential throughout any such protocol Alternative Approach: Sequential Rather Than Concurrent An arguably safer alternative to simultaneous cagrilintide dosage with retatrutide administration involves sequential optimization: Optimize one compound first Reach stable, effective dose of either cagrilintide or retatrutide Assess response Evaluate metabolic effects over 12-16 weeks Introduce second compound Only if additional effects are needed Ultra-gradual second titration Even slower escalation of the added compound Continuous reassessment Regular evaluation of whether combination provides benefits beyond monotherapy This approach provides clearer attribution of effects and side effects to specific compounds, though it significantly extends the overall timeline

Depression and stress: Todays research suggests that the underlying cause of most depression is inflammation

Some peptides are well-established prescription medications

At OVYVO, compounded liraglutide may be considered only after clinical evaluation to determine whether it is appropriate based on medical need and product availability

2,3 GLP-1 and Weight Loss GLP-1 is a hormone naturally produced in the central nervous system, intestine and pancreas